Bluetongue virus (BTV) was shown to agglutinate human, ovine and porcine erythrocytes. Removal of neuraminic acid (NA) from erythrocytes by Vibrio cholerae neuraminidase prevented their agglutination. Haemagglutination was also inhibited by N-acetyl neuraminic acid (NANA), N-glycolyl neuraminic acid (NGNA) and Nacetyl neuramin-lactose. The ability of BTV to agglutinate trypsin-treated human erythrocytes, which lack the amino-terminal domain and the single N-linked oligosaccharide of glycophorin A, suggests that the virus bound to human erythrocytes via NANA-containing, O-linked oligosaccharides. Glycoproteins with NA-containing oligosaccharides of known structure such as mucin, fetuin, alpha 1-acid glycoprotein, ovomucoid and ovine, porcine, human and equine glycophorin were examined for their ability to inhibit BTV-mediated agglutination of human, ovine and porcine erythrocytes. All glycoproteins containing NANA-or NGNA~2-6GalNAc were capable of inhibiting the agglutination of human and porcine erythrocytes. Treatment of human erythrocytes with Newcastle disease virus neuraminidase and of porcine erythrocytes with Clostridium perfringens neuraminidase to cleave preferentially the NANA-and NGNAcc2-3Gal linkages respectively, were shown to have little effect on the ability of the erythrocytes to be agglutinated by BTV. The results suggested that BTV binds to NANA-and N G N A~2-6GalNAc residues in the O-linked oligosaccharides of human and porcine glycophorins respectively and indicated the presence of different binding sites on the virus for erythrocytes from other species.
INTRODUCTION
Many viruses have the ability to agglutinate a variety of mammalian erythrocytes (LonbergHolm & Philipson, 1974; Howe & Lee, 1972; Burness, 1981) . The fact that haemagglutination is prevented by treatment of erythrocytes with bacterial neuraminidase implicates neuraminic acid(NA)-containing molecules as key sites for virus attachment. Most NA residues on erythrocytes are present in glycophorin, a relatively small, but heavily glycosylated protein (Tomita & Marchesi, 1975; Furthmayr & Marchesi, 1983; Krotkiewski, 1988) .
Glycophorins are integral membrane proteins whose extracellular amino-terminal domain contains a large number of O-linked NA-containing oligosaccharide side chains which show considerable heterogeneity in their structure and are linked to serine or threonine through Nacetylgalactosamine (GalNAc). Glycophorins from human and porcine erythrocytes also have one and two asparagine N-linked, NA-containing, complex oligosaccharide side chains, respectively (Yoshima et al., 1980; Honma et al., 1980) . In contrast equine glycophorin does not contain N-linked oligosaccharides (Murayama et al., 1981) .
Glycophorin has been shown to be the erythrocyte receptor for influenza virus (Marchesi & Andrews, 1971) , encephalomyocarditis (EMC) virus (Enegren & Burness, 1977) and reovirus (Paul & Lee, 1987 ). Reovirus appears to bind to the terminal NA residues in the N-linked oligosaccharide of human glycophorin (Paul & Lee, 1987) whereas EMC virus attachment depends on the NA residues in O-linked human glycophorin oligosaccharides (Allaway & Burness, 1986) . Using human erythrocytes modified enzymically to contain cell surface oligosaccharides, Rogers & Paulson (1983) showed that human and animal influenza viruses may bind to cells containing NA~2-6Gal or NAct2-3Gal or to both cell types. None of the viruses examined agglutinated cells containing NA~2-6GalNAc. A similar approach was used by Cahan & Paulson (t980) to show that polyoma virus agglutination of neuraminidase-treated erythrocytes was restored by the addition of NA in an ct2-3Gal linkage but was not restored by NA linked g2-6 to either Gal or GalNAc. Similarily, agglutination of asialoerythrocytes by Newcastle disease virus (NDV) was achieved following the addition of NA in an ~2-3Gal sequence (Paulson et al., 1979) .
Bluetongue virus (BTV) is a member of the orbivirus genus in the Reoviridae family. The virus contains 10 segments of dsRNA surrounded by a double-shelled capsid (Verwoerd et al., 1970 (Verwoerd et al., , 1972 . The outer fibrillar layer of the virus contains two proteins, VP2 and VPS. BTV, like other members of the Reoviridae, agglutinates erythrocytes from certain species (Van der Walt, 1980; Hubschle, 1980; Tokuhisa et al., 1981) presumably through interaction with VP2 (Cowley & Gorman, 1987) .
In sheep and cattle infected with BTV, the virus is found in association with erythrocytes (Collisson & Barber, 1983) . This association may play a role in the dissemination of virus throughout the body of the vertebrate host and/or help maintain the virus within the gut of the Culicoides vector following a blood meal. In addition, blood from viraemic animals acts as the source of virus for isolation procedures using either embryonated chicken eggs or tissue culture. In order to understand better the nature of the BTV-erythrocyte interaction, we have attempted to determine the binding site for the virus on erythrocytes from a number of animal species. The results presented here suggest that BTV binds to human erythrocytes via NAct2-6GalNAc-containing O-linked oligosaccharides of glycophorin.
METHODS
Materials. Vibrio cholerae type II and Clostridium perfringens type V neuraminidases, lithium 3,5-diiodosalicylate, 2,3-dehydroxy-3-dihydro-N-acetylneuraminic acid (DDN), fetuin (type II), bovine submaxillary mucin (type 1-5), ovalbumin, human alpha-l-acid glycoprotein, trypsin inhibitor (type III-0; ovomucoid), N-acetyl neuraminic acid (NANA) (type IV), N-glycolyl neuraminic acid (NGNA), Nacetyl neuramin-lactose, galactose, galactosamine and N-acetyl galactosamine-l-phosphate were purchased from Sigma. Human type O and horse blood were kindly provided by the Department of Pathology, Geelong Hospital and the Veterinary Research Laboratories, Werribee, Victoria, respectively. Sheep and pig blood were obtained from animals held in the Australian Animal Health Laboratory (AAHL). Blood was collected, washed in Alsever's solution and stored as described by Van der Walt (1980) . NDV, purified from infected allantoic fluid by sucrose density gradient centrifugation, was kindly provided by Dr A. J. Della-Porta, AAHL.
Glycophorins. Gtycophorins from human, equine, ovine and porcine erythrocytes were prepared using the lithium di-iodosalicylate-phenol extraction method described by Marchesi & Andrews (1971) . Analysis by SDS-PAGE and Coomassie Brilliant Blue staining indicated that human and sheep glycophorins migrated with apparent Mr values of 80 000 and 55 000 respectively. These values are approximately double those estimated for human (Tomita & Marchesi, 1975) and sheep glycophorins. Many glycophorins exist in the form of dimers even in SDS-containing solutions.
Virus and haemagglutininpreparation. An Australian isolate of BTV type 1 (BTV-1) (CS156) was grown in SVP cells in Medium 199 containing 5~ foetal calf serum as described (Eaton et al., 1987) . To prepare virus for haemagglutination, SVP cells in roller bottles were infected at an approximate multiplicity of 3 p.f.u./cell and incubated at 37 °C for 40 h. Cells were scraped from the substrate, pooled with those floating in the culture medium, pelleted, washed in phosphate-buffered saline (PBS) and lysed in 200 mM-Tri~HCI pH 8.0, containing 1 ~ Triton X-100. The nuclear-cytoskeleton fraction was pelleted, resuspended in buffer and sheared in a Dounce homogenizer. Nuclei were removed by centrifugation. Cytoplasmic (i.e. Triton X-100-soluble material) and cytoskeletal fractions were pooled, layered over 40~ sucrose in 200 mM-Tris-HC1 pH 8.0, and centrifuged onto a 66~ sucrose cushion at 39000 r.p.m, in a SW41 rotor at 4 °C for 1.5 h. The virus pellet was resuspended in 200 mMTris-HC1 pH 8-0, made up to 3~ in deoxycholate (Mertens et al., 1987) and sedimented through a sucrose column. Estimation of the haemagglutination activity and infectivity titre (as determined by plaque assay) indicated that such partially purified intracellular virus preparations had the same haemagglutination :infectivity ratio as preparations of virus particles which had been released into the culture medium of infected ceils, precipitated with ammonium sulphate and purified by centrifugation through 40~o sucrose columns as described above. However the comparison indicated that the intracellular concentration or virus haemagglutinin exceeded that released from infected cells by a factor of three to four. Attempts to purify further the haemagglutinin using sodium lauryl sarcosine (SLS) and DTT as described by Mertens et at. (1987) resulted in a large decrease in both haemagglutination and infectivity titres. Examination of the protein content of crude, partially purified and SLS/DTT-purified virus preparations showed that there was no detectable loss of VP2 from the particles during purification (Eaton et al., 1988) , indicating that the loss of haemagglutination activity was not due to a breakdown of the outer capsid layer during purification. Negative staining and electron microscopic examination of purified virus revealed the underlying capsomers of the inner capsid more clearly (Eaton et al., 1988) than in virus which had not been treated with SLS and DTT, confirming that such treatment lead to an alteration in the structure of the outer capsid layer of BTV-1 (Australia). Deoxycholate-treated, partially purified virus preparations were used as the source of viral haemagglutinin. Evidence for the virus-specificity of haemagglutinin was obtained from the observed haemagglutination inhibition (HI) by a bovine polyclonal anti-BTV-I antiserum.
Haemagglutination assay. In microtitre plates, doubling dilutions of partially purified virus in TSAG (0.02 MTris-HC1 pH 9.0, 0' 14 M-NaC1, 0.001 M-CaC12, 0.2~ bovine serum albumin and 0.0025 ~ gelatin) were mixed with an equal volume (25 ~tl) of TSAG and 50 pl of a 0.25 ~ suspension of erythrocytes, as described by Van der Walt (1980) . After 2 to 3 h at 22 °C, the reciprocal of the highest dilution producing complete haemagglutination was taken as 1 unit. In HI experiments, doubling dilutions of sugars, antiserum, glycophorins or glycoproteins in TSAG were mixed with 4 haemagglutination units of virus in an equal volume (25 ~tl) of TSAG. Following 20 rain at 22 °C, 50 Id of a 0.25~ suspension of erythrocytes was added to each well. Tests were read after 2 h.
Neuraminidase and trypsin treatment of erythroeytes. Human, ovine and porcine erythrocytes (5~) in either Earle's saline, PBS-containing 2 raM-calcium chloride or TSAG were incubated in the presence and absence of 1 milliunit/ml V. eholerae or C. perfringens neuraminidase. After incubation at 37 °C for 30 rain, 1, 2 and 3 h, cells were washed twice and used for haemagglutination assays in the usual manner. NA released from erythrocytes by neuraminidase treatment was quantified as described by Roboz et al. (1981) and Warren (1959) . Human erythrocytes in PBS (5 ~) were incubated at 37 °C with trypsin (1 mg/ml) for 30 min, 1 and 2 h. Trypsin-mediated cleavage of glycophorin A was confirmed by showing that V. cholerae neuraminidase released from trypsin-treated cells approximately 40~o of the NA released from untreated cells under identical conditions.
Neuraminidase treatment of human glycophorin. Human glycophorin in PBS was treated with V. eholerae neuraminidase as described by Paul & Lee (1987) .
RESULTS AND DISCUSSION

BTV binds to glycophorin
To determine whether glycophorin is the receptor for BTV on a number of erythrocytes, an attempt was made to inhibit BTV-mediated haemagglutination with glycophorins isolated from human, porcine, ovine and equine erythrocytes. The data in Table 1 show that agglutination of human, porcine and ovine erythroctyes by BTV was inhibited, not only by the homologous glycophorin, but also with the three heterologous glycophorins.
NA is required for erythrocyte agglutination by BTV
A role for NA in the binding of BTV to erythrocytes was indicated by the results of three experiments. First, pretreatment of human glycophorin with V. eholerae neuraminidase destroyed its inhibitory effect on BTV haemagglutination (Table 1) . Second, NANA, NGNA and N-acetyl neuramin-lactose were able to inhibit the BTV-mediated agglutination of human, ovine and porcine erythrocytes (Table 2) . Third, pretreatment of erythrocytes with V. cholerae neuraminidase eliminated their ability to be agglutinated by BTV (Table 3 ). This effect was abolished in the presence of DDN, a neuraminidase inhibitor (Schauer, 1981) (data not shown).
Location of the BTV binding site on human erythrocytes
NA may be present in both N-and O-linked oligosaccharides in glycophorins. The structure of the N-linked oligosaccharides in porcine glycophorin is not known, nor is it clear whether ovine glycophorin contains N-linked oligosaccharides. However in the case of human glycophorin A, which constitutes approximately 80~ of human glycophorin molecules (Bretscher, 1971) , a single N-linked, complex oligosaccharide at amino acid position 26 contains terminal NANA~2-6Galfll-4GlcNAc residues (Yoshima et al., 1980) . Glycophorin B, which comprises approximately 15~o of the human glycophorins does not contain an N-linked oligosaccharide. Several lines of evidence suggested that NANA in the N-linked oligosaccharide was not involved in BTV agglutination of human erythrocytes. First, alpha 1-acid glycoprotein which contains a trisaccharide identical to that in the human glycophorin N-linked oligosaccharide does not inhibit the BTV-mediated agglutination of human erythrocytes (Table  1) . Second, treatment of human erythrocytes with trypsin which removes the amino-terminal portion of glycophorin A containing the N-linked oligosaccharide (Burness & Pardoe, 1981) did not reduce the ability of human cells to be agglutinated by BTV. Third, equine glycophorin which appears to have no N-linked oligosaccharides and does not contain NAcc2-6Gal residues (Fukuda et al., 1980) is capable of inhibiting BTV-mediated agglutination of human erythrocytes (Table 1) . Fourth, N-acetyl neuramin-lactose which is a mixture of NANA~2-3Galfll-4Gl (85~) and ~2-6Galfll-4Gl (15~) is no more efficient than either NANA or NGNA in inhibiting agglutination of human erythrocytes by BTV (Table 2 ). These data suggest that BTV does not bind to the NANA in the N-linked oligosaccharide of human glycophorin and imply that binding occurs to human O-linked oligosaccharides. The ability of BTV to agglutinate equine erythrocytes (data not shown) suggests that the virus-binding site on these erythrocytes also resides in O-linked oligosaccharides. The four glycophorins used in this study inhibit the agglutination of human, ovine and porcine erythrocytes by BTV (Table 1) . They all contain a number of O-linked, NA-containing oligosaccharides with a majority of those from human, equine and ovine glycophorins consisting of the tetrasaccharide NA~2-3Galfll-3 (NAc~2-6)GalNAc. O-linked oligosaccharides lacking either one of the NA residues have been identified in equine and human glycophorin (Krotkiewski, 1988) . Porcine glycophorin differs from the other three in having an O-linked oligosaccharide structure, Galfll-3 (NAa2-6)GalNAc (Honma et al., 1980 porcine glycophorin to block agglutination of human erythrocytes by BTV suggests that the NAct2-6GalNAc, which is common to all four glycophorins, may be the site of BTV binding.
The results in Table 1 also show that agglutination of human (and porcine) erythrocytes by BTV was inhibited by glycoproteins containing NANAct2-6GaINAc (mucin, fetuin), but not by those containing NANAct2-3 or ~2-6Gal (alpha 1-acid glycoprotein, ovomucoid).
Further information on the nature of the BTV-binding site on human erythrocytes was obtained by using a linkage-specific neuraminidase. NDV neuraminidase exhibits strict specificity for NANA~2-3Gal residues (Paulson et al., 1982) . Human erythrocytes treated with NDV were not agglutinated by that virus which binds to NANAct2-3Gal residues (Paulson et al., 1979) (data not shown), but retained their ability to be agglutinated by BTV (Table 3) . This suggests that NANAct2-3Gal residues are not involved in BTV-mediated agglutination of human erythrocytes. The ability of porcine and equine glycophorins (which contain NGNA residues) to block agglutination of human erythrocytes (which contain only NANA residues) indicates that the acetyl residues are not critical for agglutination. This is confirmed by the data in Table 2 which show that NGNA and NANA are equally effective at inhibiting agglutination of human erythrocytes.
In summary, the evidence presented here suggests strongly that BTV binds to NANAct2-6GalNAc residues on the O-linked oligosaccharides of human glycophorin. The ability of BTV to agglutinate trypsin-treated human erythrocytes indicates that the site of the O-linked oligosaccharide(s) responsible may be associated either with glycophorin B or attached to glycophorin A at amino acid positions 44, 47 or 50 (Tomita & Marchesi, 1975) .
The use of linkage-specific neuraminidase to provide evidence for the BTV binding site on porcine and ovine erythrocytes
The data in Table 3 show that treatment of human cells with C. perfringens neuraminidase resulted, within 30 min, in a complete loss of agglutinating ability. In contrast, ovine erythrocytes displayed partial resistance and porcine erythrocytes appeared to be completely resistant even after 3 h incubation with this enzyme. Increasing the enzyme concentration 10-fold did not alter this result (data not shown).
An explanation for the different effects of V. cholerae and C. perfringens neuraminidases on ovine, porcine and human erythrocytes may lie in the preferred specificities of the two enzymes and the nature of the NA in the glycophorins. Human glycophorins contain only NANA (Yoshima et al., 1980) whereas glycophorins from most other animals, including pigs, contain NGNA (Fukuda et al., 1980; Kawashima et al., 1982) . Ovine glycophorin contains equal amounts of NANA and NGNA (Klimas et al., 1982) . The preference of neuraminidases for NANA-rather than NGNA-containing substrates (Corfield et al., 1981) could account for the B.T. EATON AND G. S. CRAMERI observation that human erythrocytes are more rapidly inactivated by V. cholerae neuraminidase than are ovine and porcine cells (Table 3) .
Using NGNAct2-3 lactose (NGNA~2-3Galfll-4GI) and NGNAa2-6GalNAc as substrates, Corfield et al. (1981) demonstrated that V. cholerae neuraminidase was capable of cleaving NGNA from both substrates with approximately equal efficiency, whereas the C. perfringens enzyme exhibited a slow rate of cleavage of N GNAa2-6GalNAc linkages. This information and the resistance of BTV-mediated agglutination ofovine and porcine erythrocytes to C. perfringens neuraminidase suggests that BTV may bind to glycophorin in these cells via NGNA~2-6GalNAc residues or some other C. perfringens neuraminidase-resistant NA. The decreased haemagglutination titre with treated ovine erythrocytes may be due to the cleavage of NANAbut not NGNAct2-6GalNAc linkages in ovine glycophorin.
All the glycophorins tested, including equine glycophorin which contains neither N-linked oligosaccharides nor NGNA~2-6Gal residues but does contain NGNAct2-3Gal and NGNAct2-6GalNAc residues (Fukuda et al., 1980) , block agglutination of human, porcine and ovine erythrocytes. This suggests that the NA responsible for BTV binding may lie in ct2-3Gal and/or ct2-6GalNAc linkages. The O-linked oligosaccharides in porcine glycophorin contain only NGNAa2-6GalNAc and the ability of this glycophorin to block BTV haemagglutination strongly suggests that the NA involved in ovine and porcine erythrocytes is also linked to 2-6GalNAc.
The ability of fetuin and mucin, both of which contain NANA~t2-6GalNAc, to block human and porcine and not ovine erythrocyte agglutination, suggests that the BTV-binding site differs in human and ovine erythrocytes and that BTV may contain at least two erythrocyte-binding domains which recognize NAct2-6GalNAc residues in glycophorin. One site may interact with human and porcine cells and is blocked by mucin and fetuin whereas the other may bind to ovine erythrocytes and is insensitive to these glycoproteins. The ability of glycophorins from four erythrocyte species to block human (or porcine) and ovine haemagglutination suggests that in solution all these glycophorins may present NAa2-6GalNAc residues in conformations capable of binding to both sites on the virus. The presence of a further erythrocyte-binding site on BTV seems assured because BTV-1 also agglutinates bovine erythrocytes which lack NAct2-6GalNAc in their O-linked oligosaccharides (Krotkiewski, 1988) .
